MNC and CMNC software from Terumo supports gene therapy apheresis at BWC
- Birmingham Women's and Children's NHS Foundation Trust
- West Midlands
- Below threshold - without competition
- 18 May 2026 to 18 June 2026
Birmingham Women's and Children's NHS Foundation Trust bought MNC and CMNC software from Terumo UK Limited for use in gene therapy apheresis.
The trust took licensing and support for the software straight from Terumo, the manufacturer, without a competition. The £19,560 contract was set to run for one month, from May to June 2026.
- What
- Blood collection, apheresis and component processing
- Supplier
- Terumo UK Limited
- Value
- £19,560
- How it was bought
- Below threshold - without competition
- Dates and next
- May 2026 to Jun 2026